lobbying_activities: 2516138

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2516138	d54cb81a-9c50-4855-9f17-558d3bca6eff	Q3	FAEGRE DRINKER BIDDLE & REATH LLP	12631	NATIONAL ASSOCIATION OF BOARDS OF PHARMACY	2020	third_quarter	PHA	Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs; COVID-19 response; H.R. 2482, S. 2074 - Mainstreaming Addiction Treatment Act; opposing prescription drug importation	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2020-10-19T11:46:32.347000-04:00